Jeffrey T. Liegner,John Scott Karolchyk,Bernard Covalesky,Richard Dilzer,Kallan Peters,Dennis Elias Saadeh
申请号：
US15178812
公开号：
US20160279055A1
申请日:
2016.06.10
申请国别(地区):
US
年份:
2016
代理人:
摘要：
Pharmaceutical ophthalmic compositions are described, the compositions consisting essentially of a therapeutically effective quantity of an anti-bacterial agent (such as moxifloxacin), a therapeutically effective quantity of an anti-inflammatory agent (such as prednisolone), a combination of at least two solubilizing and suspending agents (of which one is a non-ionic polyoxyethlene-polyoxypropylene block copolymer), and a carrier. Methods for fabricating the compositions and using them are also described.
